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Involvement of the 5-HT2A Receptor In The Regulation
of Hippocampal-Dependent Learning and Neurogenesis
Briony J Catlow
ABSTRACT
Aberrations in brain serotonin (5-HT) neurotransmission have been
implicated in psychiatric disorders including anxiety, depression and deficits in
learning and memory. Many of these disorders are treated with drugs which
promote the availability of 5-HT in the synapse.

Selective serotonin uptake

inhibitors (SSRIs) are known to stimulate the production of new neurons in the
hippocampus (HPC) by increasing synaptic concentration of serotonin (5-HT).
However, it is not clear which of the 5-HT receptors are involved in behavioral
improvements and enhanced neurogenesis.

The current study aimed to

investigate the effects of 5HT2A agonists psilocybin and 251-NBMeO and the
5HT2A/C antagonist ketanserin on neurogenesis and hippocampal-dependent
learning.

Agonists and an antagonist to the 5-HT2A receptor produced

alterations in hippocampal neurogenesis and trace fear conditioning.

Future

studies should examine the temporal effects of acute and chronic psilocybin
administration on hippocampal-dependent learning and neurogenesis.

vi

Chapter One
Introduction
The idea of new neurons forming in the adult central nervous system
(CNS) is a relatively new one. In the 1960’s Joseph Altman published the first
evidence of neurogenesis, or the birth of new neurons in the adult mammalian
brain (Altman, 1962; Altman, 1963; Altman & Das, 1965). Utilizing the tritiated
thymidine method (Sidman et al., 1959; Messier et al., 1958; Messier & Leblond,
1960) Joseph Altman was able to demonstrate that the subventricular zone
(SVZ) of the lateral ventricles and the dentate gyrus (DG) of the hippocampus
(HPC) produce new neurons throughout the lifespan (Altman, 1962; Altman &
Das, 1965; Altman, 1969).

For years following Altman’s discovery scientists

acknowledged the possibility of the generation of new glial cells in the adult brain
but rejected the concept of new born neurons.

With the advent of new

technologies such as the bromodeoxyuridine (BrdU) method of birth dating cells
and double labeling using immunofluorescence, adult neurogenesis has been
identified in many mammalian species including mice (Kempermann et al., 1998),
rats (Kaplan & Hinds, 1977), hamsters (Huang et al., 1998), tree shrews (Gould
et al., 1997), nonhuman primates (Gould et al., 1999b; Bernier et al., 2002) and
humans (Eriksson et al., 1998). Peter Eriksson’s discovery of new neurons in the
human HPC changed the perception of neurogenesis in the scientific community
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so now the fact that new neurons are produced in the adult brain is firmly
established.
The Anatomy of Hippocampal Neurogenesis
The HPC is divided into four areas: DG (also called area dentate, or
fascia dentata), cornu ammonis (CA, further divided into CA1, CA2, CA3 and
CA4), the presubiculum and the subiculum. This anatomical description of the
HPC has been confirmed by both gene expression and fiber connections. The
DG and areas CA form a trisynaptic circuitry within the HPC (see Figure 1.1).
Neurons in the entorhinal cortex (EC) project to dendrites of the granule cells in
the DG forming the perforant pathway. The granule cells extend their axons
(Ramon, 1952) to pyramidal neurons in area CA3, forming the mossy fiber tract
(Ribak et al., 1985). CA3 pyramidal neurons project to the contralateral (via
associational commissural pathway) and the ipsilateral CA1 region forming the
Shaffer collateral pathway.

Pyramidal neurons in CA1 extend axons to the

subiculum and from the subiculum back to EC (for detailed descriptions of
hippocampal circuitry see (Witter, 1993)).
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Figure 1.1. Anatomy of the Hippocampus. The HPC forms a trisynaptic pathway
with inputs from the Entorhinal Cortex (EC) that projects to the Dentate Gyrus
(DG) and CA3 pyramidal neurons via the perforant pathway. Granule cells in the
DG project to CA3 via the mossy fiber pathway. Pyramidal neurons in CA3
project to both the contralateral (associational commissural pathway) and the
ipsilateral CA1 region via the Schaffer Collateral Pathway.

CA1 pyramidal

neurons send their axons to the Subiculum (Sb) which in turn projects out of the
HPC back to the EC.

In normal physiological conditions, neurogenesis that occurs in the HPC is
found only in the DG and results in the generation of new granule cells. Within
the DG, progenitor cells reside in a narrow band between the DG and the hilus
(also called CA4 or plexiform layer) called the subgranular zone (SGZ) which is
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approximately 2-3 cells thick (20-25 µM) (see Figure 1.2). Neural progenitor cells
(1) divide and form clusters of proliferating cells (2). Proliferating cells exit from
the cell cycle and begin to differentiate into immature neurons (3). The immature
granule cell forms sodium currents, extends dendrites and an axon to make
connections with other cells and form synapses to become a mature neuron (4).
The SGZ contains many cell types including astrocytes (Seri et al., 2001; Filippov
et al., 2003; Fukuda et al., 2003), several types of glial and neuronal progenitor
cells (Filippov et al., 2003; Fukuda et al., 2003; Kronenberg et al., 2003; Seri et
al., 2004) and neurons in all stages of differentiation and maturation (Brandt et
al., 2003; Ambrogini et al., 2004).

Figure 1.2. Neurogenesis in the Dentate Gyrus of the Hippocampus. Neural
stem cells exist the SGZ of the DG, these cells then divide, differentiate and
mature into their phenotypic fate. Neural progenitor cells (1) divide and form
clusters of proliferating cells (2). Proliferating cells exit from the cell cycle and
begin to differentiate into immature neurons (3). The immature granule cell forms
sodium currents, dendrites and extends an axon out to make connections with
other cells and form synapses to become a mature granule cell (4).
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Regulation of Neurogenesis in the Dentate Gyrus
The proliferation and survival of neural progenitors in the adult HPC can
be influenced in a positive and negative manner by a variety of stimuli. Factors
as diverse as stress, odors, neurotrophins, psychoactive drugs such as
antidepressants, opioids and alcohol, electroconvulsive therapy, seizures,
ischemia, cranial irradiation, physical activity, learning, hormones and age
amongst many others have been linked to the regulation of neurogenesis
(Kempermann et al., 1998; Van et al., 1999b; Malberg et al., 2000; Malberg &
Duman, 2003; Tanapat et al., 2001). Some of these factors have been studied
extensively and their role in the regulation of neurogenesis is well defined. For
example, environmental enrichment and physical activity are strong positive
regulators of neurogenesis (Van et al., 1999b; Kempermann et al., 1997), while
stress and age (Cameron et al., 1993; Kempermann et al., 1998) appear to be
negative regulators of neurogenesis.
The first report of any factor increasing neurogenesis in the mammalian
brain was an enriched environment. In an experimental setting a rodent enriched
environment typically consists of a large cage, a large number of animals, toys
and a tunnel system. In order to maintain the enrichment aspect novel toys are
introduced and tunnel system is rearranged on a regular basis.

Mice

(Kempermann et al., 1997) and rats (Nilsson et al., 1999) living in an enriched
environment

exhibited

a

strong

up-regulation
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of

cell

proliferation

and

neurogenesis in the DG of the HPC. The proneurogenic effects of environmental
enrichment can be increased further depending on the age of the animal when
exposure occurs. When late adolescent/young adult animals live in an enriched
environment it enhances the ability of environmental enrichment to up-regulate
cellular proliferation and neurogenesis in the DG. In fact, when the morphology
of the HPC was examined later in life, a greater number of absolute granule cells
was observed (Kempermann et al., 1997). In aged animals (typically 18 months
or older in rodents) lower levels of neurogenesis have been observed, however
living in an enriched environment counteracts the effects of aging (Kempermann
et al., 1998).

Kempermann and colleagues demonstrated environment

enrichment during aging increases cell proliferation and neurogenesis in the DG
(Kempermann et al., 1998).

Furthermore, if animals live in an enriched

environment during mid age, basal levels of neurogenesis increase as much as
five fold in old age.
When experimentation with environmental enrichment began, novel foods
were included as apart of the environmental enrichment experience.

When

similar food was given to mice living either an enriched or control environment,
the effect of environmental enrichment was still present.

One type of diet

however, has been found to have positive effects on neurogenesis specifically,
caloric restriction (Lee et al., 2000). As an experimental manipulation caloric
restriction usually consists of limiting the amount of food an animal can eat by a
third. Caloric restriction is the only factor that has been shown experimentally to
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increase the life span of animals and it is thought that caloric restriction actually
acts as a mild stressor. It is of interest to note while environmental enrichment is
a strong positive regulator of adult hippocampal neurogenesis, it does not affect
adult neurogenesis in the olfactory system (Brown et al., 2003).
Exposure to an enriched environment increases neurogenesis in the DG
of adult rodents, however, environmental enrichment typically includes a running
wheel and increased physical activity. Physical activity is known to up-regulate
cell proliferation and neurogenesis in the DG. Rodents will take full advantage of
the opportunity to exercise on a running wheel during their active phase of their
day. Mice have been reported to run between 3 and 8 km per night on a running
wheel (Van et al., 1999a; Van et al., 1999b). Voluntary physical activity has been
shown to increase the number of progenitor cells and new neurons in the DG of
the HPC (Van et al., 1999a; Van et al., 1999b).

The effect of running on

neurogenesis is acute so that running must continue to effect neurogenesis and
once the animal no longer uses the running wheel the effect on neurogenesis will
decline.

The up-regulation of adult neurogenesis by physical activity also

increases long term potentiation (LTP) in the DG and enhances performance on
the Morris water maze (MWM) (Van et al., 1999a). The MWM is a behavioral
task that assesses memory and learning, but as part of the task the animals are
placed into a pool of water and forced to swim.

Some have argued that

swimming, being physical activity, could also influence the outcome of the task.
This point was addressed by Ehninger et al who found involuntary physical
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activity (swimming in radial arm water maze (RAWM)) had no effect on
hippocampal neurogenesis (Ehninger & Kempermann, 2003).
The mechanisms underlying the increase in neurogenesis by physical
activity are unknown however, growth factors such as insulin growth factor -1
(IGF-1), vascular endothelial growth factor (VEGF), and brain derived
neurotrophic factor (BDNF) have been strongly implicated.

IGF-1 levels are

increased in the HPC of running animals and running induced increases in
cellular proliferation and neurogenesis (Carro et al., 2001; Carro et al., 2000;
Trejo et al., 2001). This increase in neurogenesis is blocked by scavenging
circulating IGF-1 absent in IGF-1 mutants (Carro et al., 2000).

VEGF is

necessary for the effects of running on adult hippocampal neurogenesis.
Blocking

peripheral

VEGF

abolished

neurogenesis, however there were

the

running-induced

induction

of

no detectable effects on baseline

neurogenesis in non-running animal (Fabel et al., 2003).

Quantitative

polymerase chain reaction analysis revealed BDNF mRNA levels are significantly
increased in the DG of running rats (Farmer et al., 2004). BDNF is a key factor
involved in modulating neuroplasticity including LTP and neurogenesis. Infusions
of BDNF into the lateral ventricles induced neurogenesis originating in the SVZ
(Pencea et al., 2001) and BDNF knockout (KO) mice have diminished levels of
neurogenesis in the DG (Lee et al., 2002).

Like environmental enrichment,

physical activity up-regulates adult hippocampal neurogenesis, however, it does
not affect adult neurogenesis in the olfactory system (Brown et al., 2003).
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Stress severely impairs hippocampal neurogenesis.

One of the first

studies to link stress to hippocampal neurogenesis was conducted by Gould and
colleagues (1992). They found stress increased the number of dying cells in the
HPC but that the total number of granule cells in the dentate was not different
from non-stressed controls and concluded neurogenesis must be occurring to
maintain cellular balance (Gould et al., 1992).

They postulated the stress

hormone, cortisol in humans and corticosterone in rodents mediates the stress
effect on neurogenesis and went on to discover adrenalectomy (removing the
adrenal gland hence the source of endogenous corticosterone) led to an upregulation of neurogenesis and exogenous corticosterone down-regulated
cellular proliferation and neurogenesis in the DG (Cameron et al., 1993). Since
these early experiments, severe stress has been shown to downregulate cell
proliferation and consecutive stages of neuronal development using many
different paradigms. Prenatal stress caused learning deficits and had detrimental
effects on neurogenesis that lasted well into adulthood (Lemaire et al., 2000).
The effects of psychosocial stress on neurogenesis were demonstrated using the
resident-intruder model of territorial tree shrews (Gould et al., 1997).

Tree

shrews are extremely territorial and guard their environment so the introduction
of an intruder to the resident’s cage is extremely stressful. The territorial tree
shrews compete for dominance and soon after the introduction of an intruder a
dominant-subordinate relationship is established resulting in elevated cortisol and
decreased neurogenesis in the subordinate tree shrew (Gould et al., 1997).
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Predator odor triggered a stress response in prey and had detrimental effects on
cell proliferation. In rodent models, fox odor has been shown to decrease cell
proliferation and neurogenesis in the DG (Tanapat et al., 2001). Both acute and
chronic restraint stress have been shown to affect the rate of adult hippocampal
neurogenesis.

Pham and colleagues demonstrated that 6 weeks of daily

restraint stress suppressed cell proliferation and attenuated survival of the newly
born cells, resulting in a 47% reduction of granule cell neurogenesis (Pham et al.,
2003). Neurogenesis is not only affected by environmental stimuli, the absence
of stimuli, such as social isolation, negatively regulated neurogenesis. Young
rats reared in social isolation for 4-8 weeks showed decreased performance on
the MWM and decreased hippocampal neurogenesis (Lu et al., 2003). In the
learned helplessness model of depression animals are exposed to an
inescapable foot shock using avoidance testing. Exposure to inescapable shock
decreased

cell

proliferation

in

the

HPC,

extending

previous

studies

demonstrating downregulation of neurogenesis by exposure to acute stressors
(Malberg & Duman, 2003).
The key mechanism underlying the negative impact that stress has on
neuroplasticity appears to be stress hormone (glucocorticoid) secretion
(Cameron et al., 1993). Acute, severe and sometimes traumatic stress leads to
chronically high levels of glucocorticoids and alters the functioning of the
hypothalamic-adrenal-pituitary

(HPA)

axis

resulting

in

disregulation

of

glucocorticoid secretion and receptor expression. Depression is an example of a
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clinical condition associated with disturbed regulation of the HPA axis which
upsets the circadian rhythm of hormone secretion resulting in chronically
elevated glucocorticoid levels and decreased neurogenesis (Jacobs et al., 2000).
Aging is another factor known to have a strong negative influence on
neurogenesis. This has been known since the discovery of adult neurogenesis
by Altman and Das in 1965. In the original study a progressive decrease in the
levels of neurogenesis was observed after puberty and continued into old age
(Altman & Das, 1965) and this finding has been since replicated in both rats (Seki
& Arai, 1995; Kuhn et al., 1996; Cameron & McKay, 1999; Bizon & Gallagher,
2003), mice (Kempermann et al., 1998) and humans (Eriksson et al., 1998). The
highest levels of adult neurogenesis occurred in young adulthood and steadily
decreased over the lifespan. In old age (typically 18 months or older in rodents)
baseline levels of neurogenesis are extremely low, however, there are ways to
enhance neurogenesis in the aging hippocampus.

Environment enrichment

during aging increases cell proliferation and neurogenesis in the DG, however,
the effect of an enriched environment is more robust in young animals
(Kempermann et al., 1998).

Animals that lived in an enriched environment

starting at mid age had five fold increases in basal levels of neurogenesis in old
age (Kempermann et al., 1998). Cortisol (or corticosterone in rodents) levels are
elevated in aging which likely reduces baseline proliferation and neurogenesis.
Adrenalectomy in aged animals restored adult neurogenesis in the DG to a level
comparable to that of a much younger age, demonstrating corticosterone is at
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least in part responsible for the decline in neurogenesis observed in aging
(Cameron & McKay, 1999).

IGF-1 levels are increased in the HPC running

animals and running induced increases in cellular proliferation and neurogenesis
(Carro et al., 2001; Carro et al., 2000; Trejo et al., 2001). Similarly, aged animals
administered exogenous IGF-1 to restore endogenous IGF-1 levels to that of a
younger age and induced neurogenesis above controls thus counteracted the
negative effect of aging on neurogenesis (Lichtenwalner et al., 2001).
BDNF is considered a critical secreted factor modulating brain plasticity.
Physical activity, which is known to positively regulate neurogenesis and induce
LTP, induces hippocampal BDNF mRNA expression. It is thought that BDNF
may modulate the effect that physical activity has on LTP and neurogenesis
(Farmer et al., 2004).

Infusions of BDNF into the lateral ventricles induced

neurogenesis originating in the SVZ (Pencea et al., 2001) and BDNF KO mice
have diminished levels of hippocampal neurogenesis (Lee et al., 2002).

In

pathological conditions such as depression, BDNF blocks neurogenesis (which is
opposite to healthy animals) and it is now understood one of the critical functions
of BDNF is to keep neurogenesis within a physiological range. BDNF function
has been implicated in the neurogenesis hypothesis of depression, the idea
being that the antidepressants enhance neurogenesis, and BDNF is a key
regulator of this mechanism (Jacobs et al., 2000; D'Sa & Duman, 2002).
Antidepressants (including selective serotonin reuptake inhibitors (SSRIs))
induce the phosphorylation of CREB, after which CREB binds to the BDNF
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promoter and induces BDNF transcription. 5-HT2A receptor agonists, such as
2,5-dimethoxy-4-iodoamphetamine (DOI), increase BDNF mRNA expression in
the HPC (Vaidya et al., 1997).

BDNF is involved in inducing neuronal

differentiation possibly through the induction of neuronal nitric oxide synthase
(nNOS) which has been shown to stop proliferation and promote differentiation.
In vitro BDNF is a differentiation factor that can down-regulate precursor cell
proliferation (Cheng et al., 2003).
Hippocampal Neurogenesis and Learning
Memory involves the encoding, storing and recalling of information. The
HPC plays a critical role in learning and memory by converting short-term
memories into long-term memories and is pivotal in the encoding, consolidation
and retrieval of episodic memory (Squire et al., 1992; Squire, 1992). Several
studies have investigated the connection between learning and hippocampal
neurogenesis. Hippocampal mediated learning and memory has been shown to
be related to the generation of new neurons in the adult DG (Van et al., 2002;
Nilsson et al., 1999).
It has been postulated only learning tasks which are hippocampal
dependant affect progenitor cell proliferation and neurogenesis in the DG (Gould
et al., 1999a). This idea has since been demonstrated using a learning task that
is easily manipulated to be either hippocampal dependent or independent.
Hippocampal-dependent learning can be assessed using trace eye blink
conditioning. In trace conditioning the conditioned stimulus (CS), a tone, sounds
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for 5 seconds, then after a 100-1000 ms interval, the unconditioned stimulus (US)
an airpuff or eyelid shock is activated. In this way the CS and US do not overlap.
Hippocampal-independent learning can be assessed using delay eyeblink
conditioning. In delay eyeblink conditioning the tone (CS) sounds for 5 seconds
and in the last 20 ms of the tone sounding the airpuff (US) is activated. In this
way the CS and US overlap. Shors and colleagues used both trace and delay
eyeblink conditioning to demonstrate that trace eyeblink conditioning, a
hippocampal dependent task, is affected by neurogenesis whereas delay
eyeblink conditioning is not.

Mice were treated with methylazoxymethanol

acetate (MAM), an anti-mitotic agent which wipes out the progenitor cell
population in the DG and administered BrdU to birth date the cells then
performed either trace or delay eyeblink conditioning. In both trace and delay
eyeblink conditioning, saline treated mice performed well on the task and had
similar numbers of BrdU positive cells in the DG. This is in contrast to mice
treated with MAM which produced different results for trace and delay eyeblink
conditioning. In trace eyeblink conditioning MAM severely impaired learning and
obliterated BrdU incorporation in the DG, whereas, no impairment in learning was
observed after delay eyeblink conditioning despite mice being treated with MAM,
thus obliterating the progenitor pool and resulted in a dramatic reduction of BrdU
positive cells in the DG (Shors et al., 2001). These results clearly indicate that
newly generated neurons in the adult DG are affected by the formation of
hippocampal-dependent memory.
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Only certain types of hippocampal dependent tasks have been shown to
be involved in hippocampal neurogenesis (Shors et al., 2002).

This was

demonstrated using two different learning paradigms known to require the HPC,
the spatial navigation task and trace fear conditioning.

Similar to the study

mentioned earlier, mice were treated with MAM and BrdU then performance on
either behavioral task was assessed. The spatial navigation task is performed in
the MWM and required the mouse to use spatial cues in the environment (like a
black square on a wall) to navigate to and find the platform. Over trials mice
learned where the platform was located and spent less time trying to find it.
MAM failed to result in impairment in escape latency but did significantly
decreased BrdU+ cells in the SGZ, demonstrating that hippocampal progenitor
cell proliferation is not essential for this hippocampal-dependent task (Shors et
al., 2002). In a separate group of mice trace fear conditioning, which like trace
eyeblink conditioning involves a time gap between CS and US presentation was
performed.

In trace fear conditioning MAM severely impaired learning and

significantly diminished BrdU incorporation in the DG, thus providing more
evidence for the involvement of trace conditioning in hippocampal neurogenesis
(Shors et al., 2002).

The above experiments clearly demonstrate that some

forms of learning are dependent on the HPC but not all hippocampal-dependent
learning tasks require neurogenesis.
The HPC is involved in the formation and expression of memory in the
passive avoidance task in rats (Cahill & McGaugh, 1998). The logic underlying
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the passive avoidance (PA) task is that animals associate a particular
environment with an unpleasant foot shock and learn by avoiding the
environment they can avoid the aversive foot shock. Consequently, an increase
in response latency is thought to reflect the strength of the memory for the
aversive event (Sahgal & Mason, 1985). Specifically, the multi-herbal formula
BR003 increased response latency, and hence the memory of the foot shock
while also increasing the number of BrdU positive cells in the DG (Oh et al.,
2006). The PA task is relatively quick and simple but is limited in the information
it provides regarding memory, that latencies increase following shock.

A

modified version of PA, the active avoidance paradigm measures acquisition
(learning), retention (memory) and the extinction of the conditioned response.
Active avoidance is a fear-motivated associative avoidance task. In this
task the mouse has to learn to predict the occurrence of an aversive event
(shock) based on the presentation of a specific stimulus (tone), in order to avoid
the aversive event by moving to a different compartment.

The measures

recorded include number of avoidances (the mouse crossing to the other
compartment during the warning signal), number of non-responses (the mouse
failing to cross to the other compartment during the trial), response latency
(latency to avoid or escape), number of intertrial responses (i.e., crossing the
barrier within the intertrial interval), and serve as an index of learning which
allows memory to be assessed.
Many studies supported the role of the HPC in active avoidance learning.
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LTP via electrical stimulation to the perforant pathway is negatively correlated to
learning in the shuttle box avoidance task, suggesting active avoidance training
lowered the threshold frequency to induce LTP in the DG (Ramirez & Carrer,
1989).

Active avoidance learning increased the length of the postsynaptic

density in the molecular cell layer of the DG (Van et al., 1992) and increased
immunoreactivity for muscarinic receptors in the granular cell layer (Van der Zee
& Luiten, 1999). Two-way Active avoidance also increased synthesis of BDNF
(Ulloor & Datta, 2005) and cAMP response element binding (CREB) in the dorsal
HPC (Saha & Datta, 2005). Rats that learned the active shock avoidance task
(responders) had similar levels of Brdu positive and Ki67 positive cells in the DG
as non-responders, suggesting ASA has no effect on hippocampal progenitor cell
proliferation (Van der et al., 2005).
Active avoidance testing is commonly used following exposure to severe
inescapable foot shock in the learned helplessness model of depression.
Exposure to inescapable foot shock decreased progenitor cell proliferation in the
DG and this effect is reversed by chronic treatment with fluoxetine (Malberg &
Duman, 2003).

One target of antidepressant treatment is BDNF since

antidepressants

not only increase the expression of CREB in the rat HPC

(Nibuya et al., 1996) but also increase the expression of BDNF (Nibuya et al.,
1995). BDNF produced antidepressant like effects in the learned helplessness
model of depression (Shirayama et al., 2002).
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Assessing Neurogenesis
The systemic injection of thymidine, radioactively labeled with tritium was
the first method developed to label dividing cells (Messier et al., 1958). Once in
the bloodstream, tritiated thymidine competes with endogenous thymidine in all
cells in the S phase of cell division and is permanently incorporated into the DNA.
Labeled thymidine has a short half-life in vivo and labels all cells in the process of
cell division when the label is injected. At a later time point, tissue sections are
prepared and coated with a photo emulsion.

The radiation from the labeled

thymidine molecules blackens the photo emulsion, thus making visible the typical
grains of thymidine autoradiography.

Utilizing the tritiated thymidine method

(Sidman et al., 1959; Messier et al., 1958; Messier & Leblond, 1960) Joseph
Altman was able to demonstrate that the SVZ and the DG of the HPC produce
new neurons throughout the lifespan (Altman, 1962; Altman & Das, 1965;
Altman, 1969).
BrdU is a false base that competes with endogenous thymidine and
becomes permanently incorporated in the DNA during the S phase of the cell
cycle. BrdU is typically administered via injections of usually 50 - 250 mg/kg in a
single bout or over several days depending on the experimental paradigm
(Corotto et al., 1993). BrdU is advantageous because it is a permanent marker
so any cells that express BrdU can be directly related to the time BrdU was
administered thus providing the birth date of the cell. It is important to note BrdU
can be incorporated into cells that are on the verge of dying when cell death
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related mechanisms trigger DNA repair, therefore proper controls need to be
included such as immunohistochemical stains for apoptosis (caspase-3 or
TUNEL) and proliferative markers (Ki67) to determine if a cell is truly proliferative.
The rate of proliferation can be differentiated from the rate of survival by
manipulating time between BrdU injection and sacrifice so proliferating cells can
be determined by sacrificing animals 24 hours after a BrdU injection. In this way
BrdU has time to incorporate into the cell but the cell does not have time to
differentiate into a neuron, a process which takes a minimum of 72 hours.
Survival can be determined by taking the brains of animals days, weeks or even
months after BrdU injection. The phenotypic fate of the cell is determined in the
survival condition by double labeling BrdU with another marker. Table 1 presents
a summary of the common markers used to determine the phenotype of neural
progenitors.
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Marker
Ki67

Significance
Proliferation; late G1, S, G2 and M
phases

Reference
(Scholzen & Gerdes,
2000)

nuclear
Doublecortin
(DCX)

Immature neuron; microtubuleassociated protein enriched in
migratory neuronal cells. Early
neuronal marker with lineage
determined and limited self-renewal
dendritic

(Meyer et al., 2002)

III β-tubulin (Tuj1) Immature neuron; Tubulin protein
soma and processes

(Uittenbogaard &
Chiaramello, 2002)

Calretinin (CRT)

Immature neurons; calcium binding
protein transiently

(Brandt et al., 2003)

Neuronal nuclei
(NeuN)

Mature neurons; mostly in nuclei but (Mullen et al., 1992)
can be detected in cytoplasm
nucleus

Glial Fibrillary
Acidic Protein
(GFAP)

Intermediate filament protein
expressed in astrocytes.

(Fuchs & Weber,
1994)

Table 1. Antibodies used to assess phenotypic fate of progenitors
If the cell expresses Ki67 it is an early progenitor since Ki67 is a protein
expressed the G1, S, G2 and M phases of the cell cycle (Scholzen & Gerdes,
2000). Cells that express doublecortin (DCX), β -tubulin III (IIIβ-tubulin, Tuj1), or
calretinin (CRT) are immature neurons. DCX is a microtubule associated protein
transiently expressed in immature neurons (Meyer et al., 2002), Tuj1 marks
tubulin in microtubules (Uittenbogaard & Chiaramello, 2002) and CRT is a
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calcium binding protein transiently expressed in immature neurons and is
expressed in the developing neuron at a stage where DCX expression dissipates
(Brandt et al., 2003). The best and most widely used marker to identify mature
neurons is neuronal nuclei (NeuN) (Mullen et al., 1992). The expression of NeuN
is restricted to post-mitotic neurons and is predominately located in the nucleus
of neurons although it can occasionally be observed in the neurites. In order to
convincingly demonstrate neurogenesis, cells are double labeled with BrdU plus
NeuN, which clearly demonstrates that the cell was born around the time of BrdU
injection and survived to differentiate into a neuron. Cell survival depends on
many factors including the ability of the cell to form dendrites, an axon,
synthesize neurotransmitter, receptors and establish functional connections with
other cells. Cells that don’t establish functional connections will most likely die.
It is possible to assess neurogenesis using methods other than the BrdU
and

tritiated

thymidine

methods.

Using

immunohistochemical

and

immunofluorescent techniques, cells can be stained for markers of immature
neurons that are transient and only present in newly formed neurons. Brandt and
colleagues (2003) elegantly demonstrated this method by defining time periods
of development in which cells express particular markers double-labeled with
BrdU (Brandt et al., 2003). BrdU is still the only way to birth date cells so for
establishing the method it was essential to know the exact age of cells. The
expression of CRT plus BrdU positive cells was greatest 1 to 2.5 weeks after
BrdU injection and the number of double-labeled cells was negligible at 4 weeks,
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demonstrating CRT is transient. If a cell expressed DCX or CRT, that cell can be
positively identified as an immature neuron, thus estimates of DCX or CRT
positive cells in the DG represent estimates of neurogenesis.
Serotonergic Innervation in the Dentate Gyrus
Serotonin (5-HT) is a modulatory neurotransmitter in the central nervous
system which is important in the regulation of vital brain functions such as
feeding (Lucki, 1992), thermoregulation (Feldberg & Myers, 1964), sleep (Jouvet,
1967) and aggression (Sheard, 1969).

In psychopathological states such as

depression (Pinder & Wieringa, 1993), eating disorders (Leibowitz & ShorPosner, 1986) and anxiety serotonergic signaling is disturbed.
In the mammalian brain 5-HT is produced by neurons in the raphe nucleus
(RN) which project to many areas of the brain via the medial forebrain bundle
(MFB) (Azmitia & Segal, 1978; Parent et al., 1981). Neurons from RN innervate
virtually all brain areas with dense innervation occurring in the HPC, cerebral
cortex, striatum, hypothalamus, thalamus, septum and olfactory bulb (Jacobs &
Azmitia, 1992; Leger et al., 2001). The innervation of serotonergic fibers to areas
within the HPC is variable (Moore & Halaris, 1975; Vertes et al., 1999; Bjarkam et
al., 2003). The DG is innervated with serotonergic fibers in both the molecular
layer and the hilus with particularly dense innervation projecting to the SGZ
where they synapse with interneurons (Halasy & Somogyi, 1993).
5-HT activates fifteen known receptors, many of which are expressed in
the DG (el et al., 1989; Tecott et al., 1993; Vilaro et al., 1996; Djavadian et al.,

22

1999; Clemett et al., 2000; Kinsey et al., 2001). Most of the 5-HT receptors
interact with G proteins except for the 5-HT3A receptors, which are ligand-gated
ion channel receptors. The 5-HT3 receptors (subtypes 5-HT3A and 5-HT3B) are
ligand-gated Na+ ion channels and their activation leads to the depolarization of
neurons (Barnes & Sharp, 1999).

The 5-HT1 family of receptors (including

subtypes 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F) are coupled to the Gi
protein which, when activated decreases the activity of adenylyl cyclase thus
decreasing the rate of formation of cyclic adenosine monophosphate (cAMP).
Activation of 5-HT1 receptors can lead indirectly to the opening of K+ channels
therefore increasing the conductance of the cell membrane for K+ ions.
Activation of 5-HT4, 5-HT6, 5-HT7, receptors are coupled to Gs proteins which
have the opposite effect. They increase the activity of adenylyl cyclase, increase
the rate of cAMP formation and decrease K+ conductance (Thomas et al., 2000;
Raymond et al., 2001). The 5-HT2 receptors (including subtypes 5-HT2A, 5-HT2B,
5-HT2C) are coupled to Gq proteins and activate phospholipase C (PLC),
increasing the rate of formation of inositol triphosphate (IP3) and diacylglyerol
leading to the increased formation of protein kinase C (PKC) (Kurrasch-Orbaugh
et al., 2003; Ananth et al., 1987).
Serotonin and Neurogenesis in the Dentate Gyrus
While several factors regulate the rate of generation of new cells in the
adult DG, one of the most important known factors is 5-HT.

Malberg and

colleagues found increased levels of 5-HT resulted in the increased rate of
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proliferation of neural progenitors in the DG (Malberg et al., 2000). Administering
5,7-dihydrosytryptamine (5,7-DHT), a serotonergic neurotoxin into the RN and
caused the destruction of axons and serotonergic cells and resulted in a
decreased in the number of BrdU-labeled cells in the DG (Brezun & Daszuta,
1999).

The 5,7-DHT lesion resulted in around a 60% depletion of the

serotonergic innervation to the DG which lasted for one month.

After two

months, reinnervation to the DG was observed with the sprouting of serotonergic
axons so that by the third month there was no observable difference between the
5,7-DHT and vehicle in newly generated cells or serotonergic innervation (Brezun
& Daszuta, 2000).
Many serotonergic receptors have been implicated in the regulation of
neurogenesis in the DG. In vitro, when the 5-HT1A receptor agonist, 8-OH-DPAT
was added to a medium in which cultured fibroblasts transfected with the 5-HT1A
receptor were present, the rate of cell divisions increased (Varrault et al., 1992).
In vivo, 5-HT1A receptor antagonists (NAN-190, p-MPPI and WAY-100635)
decreased the number of progenitors in the DG by approximately 30% (Radley &
Jacobs, 2002) and injections of 5-HT1A receptor agonists increased the number
of BrdU positive cells in the DG (Santarelli et al., 2003). Similarly, Banasr and
colleagues showed various 5-HT1 receptor agonists increase the number of BrdU
labeled cells in the subgranular layer.

Acute administration of the 5-HT2A/C

receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI), 5-HT2C receptor
agonist RO 600175, and 5-HT2C receptor antagonist SB 206553 had no effect of
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cell proliferation in the HPC, whereas the 5-HT2A/C receptor antagonist ketanserin
produced a 63% decrease in BrdU incorporation (Banasr et al., 2004). A recent
study found acute ketanserin decreased proliferation whereas chronic ketanserin
increased proliferation in the DG (Jha et al., 2008). No effect on proliferation in
the DG was observed after DOI or lysergic acid diethylamide (LSD) were
administered either acutely or once daily for seven consecutive days (chronic)
(Jha et al., 2008).
The 5-HT2A receptor is involved in the regulation of BDNF in the HPC
(Vaidya et al., 1997). DOI alone and in combination with selective 5-HT2A and 5HT2C receptor antagonists decreased the expression of BDNF mRNA in the HPC.
Interestingly, the decrease in BDNF mRNA expression was blocked by the 5HT2A receptor antagonist but not the 5-HT2C receptor antagonist, implicating the
5-HT2A receptor in the regulation of BDNF expression. In addition, the stressinduced reduction in BDNF expression in the HPC was blocked by a 5-HT2A/C
receptor antagonist (Vaidya et al., 1997).
Psilocybin (PSOP)
PSOP (4-phosphoryloxy-N,N-dimethyltryptamine) is the main active agent
in “magic mushrooms” and is categorized as a indole hallucinogen. First isolated
from psilocybe mexicana, a mushroom from Central America by Albert Hofmann
in 1957, PSOP was then produced synthetically in 1958 (Hofmann et al., 1958a;
Hofmann et al., 1958b). PSOP is converted into the active metabolite psilocin (4hydroxy-N,N-dimethyltryptamine) which may produce some of the psychoactive
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effects of PSOP.

The chemical structure of PSOP (C12H17N2O4P) and the

metabolite, psilocin (C12H16N2O) are similar to 5-HT (C10H12N2O), the main
neurotransmitter which they affect (see Figure 1.3).
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Figure 1.3. Chemical structure of Psilocybin, Psilocin and Serotonin.

In vivo studies in mice have shown the LD50 of PSOP via intravenous
administration to be 280 mg/kg (Cerletti & Konzett, 1956; Cerletti, 1959).
Autonomic effects of 10 mg/kg/sc in mice, rats, rabbits, cats and dogs include
mydriasis,

piloerection,

irregularities

in

heart

and

breathing

rate

and

hyperglycemic and hypertonic effects (Cerletti & Konzett, 1956; Cerletti, 1959).
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These effects were interpreted as an excitatory syndrome caused by stimulation
of the sympathetic nervous system with one large exception being the absence
of hyperlocomotion (Monnier, 1959).
PSOP

exerts

psychoactive

effects

by

altering

serotonergic

neurotransmission by binding to 5-HT1A, 5-HT1D, 5-HT2A and 5-HT2C receptor
subtypes (Passie et al., 2002). PSOP binds to the 5-HT2A receptor (Ki = 6 nM)
with high affinity and to a much lesser extent to the 5-HT1A receptor subtype (Ki =
190 nM) (McKenna et al., 1990). However, PSOP has a lower affinity for 5-HT2A
and 5-HT2C receptors compared to lysergic acid diethylamide (LSD), a similar
indole hallucinogen (Nichols, 2004). In contrast to LSD, PSOP has a very low
affinity to DA receptors and only extremely high doses affect NE receptors.
PSOP has been shown to induce schizophrenia-like psychosis in humans, a
phenomenon attributed to the action of PSOP through 5-HT2A receptor action.
Specifically, human volunteers were pretreated with ketanserin, an antagonist to
the 5-HT2A/C receptor, then administered 0.25 mg/kg p.o. PSOP and the
psychotomimetic effects of PSOP were completely blocked (Vollenweider et al.,
1998). Since blocking the 5-HT2A receptor prevented the psychotropic effect of
PSOP it appears as though the actions of PSOP are mediated via the activation
of 5-HT2A receptors. A recent study tested PSOP-induced stimulus control and
found 5-HT2A receptor antagonists prevented rats from recognizing PSOP in a
drug discrimination task, an effect which was not observed with 5-HT1A receptor
antagonists (Winter et al., 2007).

Repeated daily administration of PSOP
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selectively downregulated 5-HT2A receptors in the rat brain (Buckholtz et al.,
1990; Buckholtz et al., 1988; Buckholtz et al., 1985). PSOP binds to the 5-HT2A
receptor and stimulates arachidonic acid and consequently, the PI pathway
resulting in the activation of PKC (Kurrasch-Orbaugh et al., 2003).

This

dissertation sought to evaluate the involvement of the 5-HT2A receptor in the
regulation of hippocampal neurogenesis and hippocampal-dependent learning.
Specific Aims
The present study investigated the role of 5-HT2A receptor on hippocampal
neurogenesis and hippocampal-dependent learning. The effects of acute and
chronic 5-HT2A receptor agonists and an antagonist on the survival and
phenotypic fate of progenitor cells in the DG were assessed using
immunofluroescent techniques. In addition the effects of acute PSOP on trace
fear conditioning were used to assess learning and memory.
Specific Aim 1. To evaluate the effect of acute 5-HT2A receptor agonists
and an antagonist on the survival and phenotypic fate of hippocampal progenitor
cells.

It was hypothesized PSOP and 251-NBMeO, both 5-HT2A receptor

agonists positively regulate neurogenesis in the DG of the HPC, and ketanserin,
a 5-HT2A/C receptor antagonist downregulates hippocampal neurogenesis.
Specific Aim 2. To elucidate whether PSOP affects learning and memory
using the trace fear conditioning paradigm. It was hypothesized acute exposure
to PSOP would enhance hippocampal-dependent learning and ketanserin would
impair learning on the trace fear conditioning task.
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Chapter Two
Involvement of the 5HT2A receptor in the Regulation of
Adult Neurogenesis in the Mouse Hippocampus
Abstract
Selective serotonin uptake inhibitors (SSRIs) are known to stimulate the
production of new neurons in the hippocampus (HPC) by increasing synaptic
concentration of serotonin (5-HT).

The delay in the appearance of anti-

depressant effects corresponds to the time required to generate new neurons.
However, it is not clear which of the many serotonergic receptors in the HPC are
responsible for the enhanced neurogenesis. The current study evaluated the
effects of the acute and chronic administration of 5HT2A agonists psilocybin and
251-NBMeO
neurogenesis.

and

the

5HT2A/C

antagonist

ketanserin

on

hippocampal

To investigate the effects of acute drug administration mice

received a single injection of varying doses of psilocybin, 251-NBMeO,
ketanserin or saline followed by i.p. injections of 75 mg/kg bromodeoxyuridine
(BrdU) for 4 consecutive days followed by euthanasia two weeks later.

For

chronic administration 4 injections of psilocybin, ketanserin or saline were
administered weekly over the course of one month. On days following drug
injections mice received an injection of 75 mg/kg BrdU and were euthanized two
weeks after the last drug injection.
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Unbiased estimates of BrdU+ and

BrdU/NeuN+ cells in the dentate gyrus (DG) revealed a significant dose
dependent reduction in the level of neurogenesis after acute 5HT2A receptor
agonist or antagonist administration.

Interestingly, chronic administration of

psilocybin increased the number of newborn neurons in the DG while the
antagonist suppressed hippocampal neurogenesis, suggesting the 5HT2A
receptor appears to be involved in the regulation of hippocampal neurogenesis.
Introduction
Evidence suggests neurogenesis occurs throughout the lifespan in two
specific regions of the adult brain, the subventricular zone (SVZ) and the
subgranular zone (SGZ) of the DG (Altman J, 1962; Altman & Das, 1965; Altman
J, 1969). The proliferation and survival of neural progenitors in the adult HPC
can be influenced by a variety of stimuli including stress, age, physical activity
and depression (Gould et al., 1992; Kempermann et al., 1998; Van et al., 1999b;
Malberg et al., 2000). Antidepressant medications such as selective 5-HT uptake
inhibitors (SSRIs) enhance the production of new born neurons in the DG of the
HPC (Malberg et al., 2000). However, this effect is time specific with chronic
administration (14 days or more) enhancing neurogenesis but not acute
treatment (Malberg et al., 2000). Interestingly, there is a delay in the appearance
of antidepressant effects which corresponds to the time required to generate new
neurons (Santarelli et al., 2003) suggesting an enhancement of neurogenesis
may mediate the behavioral effects of antidepressants.
The requirement of chronic administration of antidepressant medications
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to enhance neurogenesis is likely due to number of factors.

Antidepressant

treatments upregulated the expression of brain-derived neurotrophic factor
(BDNF) in the HPC (Nibuya et al., 1995). BDNF knockout mice have diminished
levels of neurogenesis in the DG (Lee et al., 2002) and infusions of BDNF into
the lateral ventricles induced neurogenesis originating in the SVZ (Pencea et al.,
2001).
The involvement of 5-HT in the regulation of neurogenesis may be
mediated through different 5-HT receptor subtypes expressed on cells in the
neurogenic microniche (Barnes & Sharp, 1999). The 5-HT2A receptor is involved
in the regulation of BDNF in the HPC (Vaidya et al., 1997). 2,5-dimethoxy-4iodoamphetamine (DOI), a 5-HT2A/C receptor agonist decreased the expression of
BDNF mRNA in the HPC (Vaidya et al., 1997). Interestingly, the decrease in
BDNF mRNA expression was blocked by the 5-HT2A receptor antagonist but not
the 5-HT2C receptor antagonist, implicating the 5-HT2A receptor in the regulation
of BDNF expression in the HPC (Vaidya et al., 1997). Acute administration of
DOI, 5-HT2C receptor agonist RO 600175, or the 5-HT2C receptor antagonist SB206553 had no effect on cell proliferation, whereas the 5-HT2A/C receptor
antagonist ketanserin produced a 63% decrease in BrdU incorporation (Banasr
et al., 2004).

A recent study found acute ketanserin decreased proliferation

whereas chronic ketanserin increased proliferation in the DG (Jha et al., 2008).
No effect on proliferation in the DG was observed after DOI or lysergic acid
diethylamide (LSD) were administered either acutely or once daily for seven
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consecutive days (chronic) (Jha et al., 2008). However, daily doses of LSD or
psilocybin (PSOP) produce rapid tolerance to the drug and resulted in a selective
downregulation of the 5HT2A receptor (Buckholtz et al., 1990; Buckholtz et al.,
1985). Therefore, in order to investigate the role of the 5HT2A receptor in the
regulation of hippocampal neurogenesis the current study evaluated the effects
of acute and repeated intermittent administration of 5HT2A agonists and the
5HT2A/C antagonist ketanserin on hippocampal neurogenesis.
Materials and Methods
Subjects.

C57BL/6J male mice (30-40g) were housed in standard

laboratory cages and left undisturbed for 1 week after arrival at the animal facility.
All mice had unlimited access to water and laboratory chow and were maintained
in a temperature and humidity controlled room on a 12:12 light/dark cycle with
light onset at 7:00

AM.

All National Institutes for Health (NIH) guidelines for the

Care and Use of Laboratory Animals were followed (National Institutes of Health,
2002).
Drugs. 251-NBMeO was synthesized in the laboratory of Dr David Nichols
(Braden et al., 2006).

PSOP was provided by Dr Francisco Moreno from

University of Arizona. Ketanserin (+)-tartrate salt (#S006, St. Louis, MO) and 5Bromo-2′-deoxyuridine (#B5002, St. Louis, MO) were supplied by Sigma-Aldrich
Inc.
General Procedure. Acute Administration: A total of 48 C57BL/6 mice
received a single injection of 0.1 mg/kg PSOP (n=6), 0.5 mg/kg PSOP (n=6), 1.0
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mg/kg PSOP (n=6), 0.1 mg/kg 251-NBMeO (n=6), 0.3 mg/kg 251-NBMeO (n=6),
1.0 mg/kg 251-NBMeO (n=6), 1.0 mg/kg ketanserin (n=6) or saline (n=6). Mice
received an intraperitoneal (i.p.) injection of 75 mg/kg BrdU once daily for 4 days
following drug administration and were euthanized two weeks after the last drug
injection. Mice were euthanized with nembutal then transcardially perfused with
0.9% saline followed by 4% paraformaldehyde.

Brains were stored in 4%

paraformaldehyde, transferred to 20% sucrose solution and sectioned coronally
using a cryostat (Leica, Germany) at 30µM in a 1:6 series and stored in 24-well
plates in cryoprotectant at -20ºC. Repeated Intermittent Administration: A total
of 31 C57BL/6 mice received 4 i.p. injections of either 0.5 mg/kg PSOP (n=6), 1.0
mg/kg PSOP (n=7), 1.5 mg/kg PSOP (n=6), 1.0 mg/kg ketanserin (n=6) or 0.9%
saline solution (n=6) over the course of one month on days 1, 8, 15, and 22.
Each day following drug administration 75 mg/kg BrdU was injected i.p. All mice
were euthanized two weeks after the last drug injection according to the above
procedures.
Immunofluorescence. For the double labeling of progenitor cells in the DG
free-floating sections were denatured using 2N HCl and neutralized in 0.15M
borate buffer then washed in PBS. Tissue was blocked in PBS+ (PBS, 10%
normal goat serum, 1% 100x Triton X, 10% BSA) for 1 hour at 4ºC and incubated
for 48 hours at 4ºC in an antibody cocktail of rat monoclonal anti-BrdU (AbD
Serotec, Raleigh NC, #OBT0030G, 1:100) plus mouse anti-NeuN (Chemicon,
1:100) in PBS. Sections were washed in PBS and incubated in a secondary
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antibody cocktail of goat anti-rat IgG Alexa Fluor 594 (1:1000, Invitrogen, Eugene
OR) plus goat anti-mouse (1:400, Invitrogen) and coated with vectorshield
mounting medium (Invitrogen).
Quantitation.

For the quantification of doubled labeled cells using

immunofluroescence, the number of BrdU+ and BrdU/NeuN+ labeled cells were
estimated using every 6th section taken throughout the DG (every 180 microns).
To avoid counting partial cells a modification to the optical dissector method was
used so that cells on the upper and lower planes were not counted. The number
of BrdU+ cells counted in every 6th section was multiplied by 6 to get the total
number of BrdU+ or BrdU/NeuN+ cells in the DG (Shors et al 2002). Positive
labeling was verified by confocal microscopy (Zeiss).
Design and analyses. Separate one-way analyses of variance (ANOVA)
were used to evaluate the acute and chronic effects of 5-HT2A receptor agonists
and an antagonist on hippocampal neurogenesis. For acute drug administration
separate one-way ANOVA was used to determine the effects of Drug [PSOP
(saline, 0.1 mg/kg, 0.5 mg/kg, 1.0 mg/kg), 251-NBMeO (saline, 0.1 mg/kg, 0.3
mg/kg, 1.0 mg/kg)] and a two-tailed t-test (saline, 1.0 mg/kg ketanserin) was
used to establish differences in cell survival and neurogenesis. For chronic drug
administration a separate one-way ANOVA was used to determine the effects of
Dose (saline, 0.5 mg/kg PSOP, 1.0 mg/kg PSOP, 1.5 mg/kg PSOP, 1.0 mg/kg
ketanserin) on cell survival and neurogenesis. When appropriate, post hoc
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analyses such as Bonferroni were used to isolate Drug effects. All statistical
analyses were determined significant at the 0.05 alpha level.
Results
Effects of Acute Administration of 5-HT2A receptor agonists and an
antagonist in vivo on Cell Survival and Neurogenesis in the Hippocampus. In
order to investigate the effects of acute PSOP administration on cell survival and
neurogenesis mice (n = 6-7 per condition) were injected with PSOP (0.1, 0.5, or
1.0 mg/kg), 251-NBMeO (0.1 mg/kg, 0.3 mg/kg, 1.0 mg/kg), ketanserin (1.0
mg/kg) or 0.9% saline solution then received 75 mg/kg BrdU once daily for 4
days following drug administration followed by euthanasia two weeks after the
last drug injection. A one-way ANOVA detected significant differences in the
total number of surviving BrdU+ cells in the DG as a result of acute PSOP
treatment [F(3,20)=6.64, p=0.003]. As can be seen in Figure 2.1A a significant
decrease in the number of surviving BrdU+ cells was observed after 1.0 mg/kg
PSOP compared to saline (indicated by *).
The

phenotypic

fate

of

surviving

cells

was

determined

by

immunofluorescent labeling of BrdU and NeuN. A one way ANOVA revealed a
significant effect of dose on the number of double labeled neurons in the DG
[F(3,20)=10.26, p=0.0003]. As can be seen in Figure 2.1B, acute administration
of 1.0 mg/kg PSOP significantly diminished the number of BrdU/NeuN+ cells
compared to saline (p<0.05). These data suggest acute administration of 1.0
mg/kg PSOP, a 5HT2A agonist downregulated neurogenesis in the DG.
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Figure 2.1. Effect of Acute PSOP Administration on Hippocampal Neurogenesis.
Mice (n = 6 per condition) were injected with PSOP (0.1, 0.5, or 1.0 mg/kg) or
saline then received 75 mg/kg BrdU once daily for 4 days following drug
administration followed by euthanasia two weeks after drug injection. A) The
total number of BrdU+ cells in the DG were significant diminished after a single
injection of 1.0 mg/kg PSOP (p<0.05). B) Acute administration of 1.0 mg/kg
PSOP significantly diminished the number of BrdU/NeuN+ cells compared to
saline (p<0.05). These data suggest acute administration of 1.0 mg/kg PSOP, a
5HT2A agonist downregulated neurogenesis in the DG of the HPC. * indicates a
significant difference from saline.
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Figure 2.2. Representative photomicrographs showing the effects of acute
PSOP on hippocampal neurogenesis. NeuN+ cells (left), BrdU+ cells (center)
and NeuN/BrdU+ cells (right). Saline (A-C), 0.1 mg/kg PSOP (D-F), 0.5 mg/kg
PSOP (G-I) and 1.0 mg/kg PSOP (J-L). Scale = 50 μM
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A one-way ANOVA detected significant differences in the total number of
surviving BrdU+ cells in the DG as a result of acute 251-NBMeO treatment
[F(3,20)=9.00, p=0.0004]. There was a significant decrease in the number of
surviving BrdU+ cells after acute administration of 0.1, 0.3 and 1.0 mg/kg 251NBMeO compared to saline (see figure 2.3A, indicated by *).
In addition, there was a significant effect of drug on the number of double
labeled neurons in the DG [F(3,20)=3.00, p=0.03]. As can be seen in Figure
2.3B, 1.0 mg/kg 251-NBMeO significantly diminished the number of new born
neurons in the DG compared to saline (p<0.05, indicated by *). These data
suggest acute administration of the selective 5-HT2A receptor agonist, 251NBMeO, attenuated hippocampal neurogenesis.
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Figure 2.3.

Effect of the selective 5-HT2A receptor agonist, 251-NBMeO on

hippocampal neurogenesis. Mice (n = 6 per condition) were injected with 251NBMeO (0.1, 0.3, or 1.0 mg/kg) or saline then received 75 mg/kg BrdU once
daily for 4 days following drug administration followed by euthanasia two weeks
after drug injection. A) There was a significant decrease in the total number of
BrdU+ cells in the DG after the administration of 251-NBMeO (p<0.05). B) The
number of new born neurons was significantly decreased after 1.0 mg/kg of 251NBMeO compared to saline (p<0.05), suggesting acute administration of the
5HT2A receptor agonist downregulated neurogenesis in the DG of the HPC.
* indicates a significant difference from saline.
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Figure 2.4. Representative photomicrographs showing the effects of the
selective 5-HT2A receptor agonist 251-NBMeO on hippocampal neurogenesis.
NeuN+ cells (left), BrdU+ cells (center) and NeuN/BrdU+ cells (right). Saline (AC), 0.1 mg/kg 251-NBMeO (D-F), 0.3 mg/kg 251-NBMeO (G-I) and 1.0 mg/kg
251-NBMeO (J-L). Scale = 100 μM
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Interestingly, acute administration of the 5-HT2A/C receptor antagonist
ketanserin produced similar effects on neurogenesis as high doses of the 5-HT2A
receptor agonists. As can be seen in figure 2.5, the total number of BrdU+ cells
in the DG was significantly decreased after 1.0 mg/kg ketanserin [t(10)=3.0,
p=0.008], suggesting that the 5-HT2A/C receptor is involved in the regulation of cell
survival in the HPC. Furthermore, acute ketanserin decreased the total number
of

BrdU/NeuN

positive

cells

compared

to

saline

[t(10)=3.0,

p=0.02]

demonstrating that antagonism of the 5-HT2A/C receptor negatively regulated the
number of new born neurons generated in the DG of the HPC.
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Figure 2.5. Acute Administration of the 5-HT2A/C receptor antagonist ketanserin
negatively regulated cell survival and neurogenesis in the HPC. Mice (n = 6 per
condition) were injected with 1.0 mg/kg ketanserin or saline then received 75
mg/kg BrdU once daily for 4 days following drug followed by euthanasia two
weeks after drug injection. Ketanserin decreased the total number of BrdU+ (A)
and BrdU/NeuN positive cells (B) suggesting that antagonism of the 5-HT2A/C
receptor negatively regulated cell survival and neurogenesis in the HPC.
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Figure 2.6. Representative photomicrographs showing the effects of the 5-HT2A/C
receptor antagonist ketanserin on neurogenesis in the dentate gyrus. NeuN+
cells (left), BrdU+ cells (center) and NeuN/BrdU+ cells (right). Saline (A-C), 1.0
mg/kg ketanserin (D-F). Scale = 100 μM

Effects of Repeated Intermittent PSOP Administration on Progenitor Cell
Survival and Neurogenesis in the Hippocampus.

In order to investigate the

effects of repeated intermittent PSOP administration on cell survival mice (n = 67 per condition) were injected with PSOP (0.5, 1.0, or 1.5 mg/kg), 1.0 mg/kg
ketanserin or 0.9% saline solution once weekly for 4 weeks. Each day following
drug administration, mice were administered 75 mg/kg BrdU and sacrificed two
weeks after last drug injection. ANOVA failed to reveal differences in the total
number of BrdU+ cells in the DG as a result of repeated intermittent drug
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treatment [F(4,26)=2.20, p=0.09]. As can be seen in Figure 2.7A a trend toward
an increase in the number of surviving cells was observed after high doses of
PSOP.
The

phenotypic

fate

of

surviving

cells

was

determined

by

immunofluorescent labeling of BrdU and NeuN. ANOVA revealed a significant
effect of Dose on the number of double labeled neurons in the DG [F(4,26)=3.15,
p=0.02]. As can be seen in Figure 2.7B, chronic administration of 1.5 mg/kg
PSOP significantly increased the number of BrdU/NeuN+ cells compared to
saline and ketanserin (p<0.05) (indicated by *). These data suggest repeated
intermittent administration of PSOP, a 5HT2A agonist upregulated neurogenesis
in the DG of the HPC.
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Figure 2.7.

Effect of Repeated Intermittent PSOP Administration on

Hippocampal Neurogenesis.

Mice (n = 6-7 per condition) were injected with

PSOP (0.5, 1.0, or 1.5 mg/kg), 1.0 mg/kg ketanserin or saline once weekly for 4
weeks.

Each day following drug administration, mice were administered 75

mg/kg BrdU and sacrificed two weeks after last drug injection.

A) The total

number of BrdU+ cells in the DG did not differ as a result of repeated intermittent
drug treatment, however, a trend toward an increase in the number of surviving
cells was observed after high doses of PSOP.

B) Repeated intermittent

administration of 1.5 mg/kg PSOP significantly increased the number of
BrdU/NeuN+ cells compared to saline and ketanserin (p<0.05).

These data

suggest repeated intermittent administration of high doses of PSOP, a 5HT2A
agonist upregulated neurogenesis in the DG.
* indicates a significant difference from saline and ketanserin.
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Figure 2.8. Representative photomicrographs showing the effects of repeated
intermittent PSOP or ketanserin administration on neurogenesis in the DG.
49

NeuN+ cells (left), BrdU+ cells (center) and NeuN/BrdU+ cells (right). Saline (AC), 0.5 mg/kg PSOP (D-F), 1.0 mg/kg PSOP (G-I), 1.5 mg/kg PSOP (J-L), and
1.0 mg/kg Ketanserin (M-O). Scale = 100 μM

Discussion
The present investigation illustrates the involvement of the 5-HT2A receptor
in the regulation of neurogenesis in the DG of the HPC. Acute administration of
low doses of PSOP (0.1 and 0.5 mg/kg) did not alter neurogenesis, however,
higher doses of PSOP (1.0 mg/kg) decreased neurogenesis two weeks after drug
exposure (Figure 2.1). In addition, acute administration of the potent 5-HT2A
receptor agonist 251-NBMeO (Figure 2.3) and the 5-HT2A/C receptor antagonist
ketanserin (Figure 2.5) decreased hippocampal neurogenesis. Acute ketanserin
(1-5 mg/kg) administered within 4 hours of sacrifice decreased the number of
BrdU+ cells in the DG, indicating a reduction in cell proliferation (Banasr et al.,
2004; Jha et al., 2008).

The present study extends these findings by

demonstrating that acute ketanserin decreases the number of BrdU+ and
BrdU/NeuN+ cells 2 weeks after drug administration, indicating a reduction in cell
survival and neurogenesis after exposure to acute ketanserin.
The current study reports that repeated intermittent administration of high
doses of PSOP (1.5 mg/kg) increased neurogenesis in the DG (see Figure 2.7).
A recent study investigated the effects of chronic DOI, LSD and ketanserin
administration on the number of Brdu+ cells in the DG (Jha et al., 2008). They
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report no effect of chronic DOI or LSD on progenitor cell proliferation but
observed an increase in the number of BrdU+ cells in the DG after chronic
ketanserin. There are several methodological differences between the studies
which may account for the different results, namely drug administration protocol,
doses of compounds administered and administration protocol of BrdU. Jha and
colleagues administered DOI (8 mg/kg), LSD (0.5 mg/kg) or ketanserin (5 mg/kg)
once daily for seven consecutive days for the chronic drug administration
protocol (Jha et al., 2008). The current investigation administered PSOP (0.5,
1.0 or 1.5 mg/kg) or ketanserin (1.0 mg/kg) 4 times over the course of one month
so that injections were given one week apart. This was a critical consideration in
our experimental design given that daily doses of LSD, PSOP or other 5-HT2A
receptor agonists produce rapid tolerance to the drug and results in a selective
downregulation of the 5HT2A receptor (Buckholtz et al., 1990; Buckholtz et al.,
1985; Buckholtz et al., 1988).

Jha and colleagues administered BrdU (200

mg/kg) 2 hours after the last injection of DOI, LSD or ketanserin and sacrificed
the animals 24 hours later (Jha et al., 2008). In the current study BrdU (75
mg/kg) was administered 24 hours after each drug injection and mice were
sacrificed two weeks after the last drug injection so that time between the first
BrdU injection and sacrifice was 6 weeks. This allowed for the assessment of
neurogenesis giving time for the birth-dated cells (BrdU labeled) to mature into
neurons.
Brain derived neurotropic factor (BDNF) has been implicated in synaptic
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plasticity (Kang et al., 1997; Pang et al., 2004; Tyler et al., 2002) through the
modulation of synapse formation and dendritic spine growth in the HPC (Bamji et
al., 2006; Tyler & Pozzo-Miller, 2001; Tyler & Pozzo-Miller, 2003).

Chronic

administration of 5-HT agonists (including SSRIs) upregulate BDNF mRNA
expression in the HPC (Nibuya et al., 1995; Nibuya et al., 1996).

Evidence

suggests that the 5-HT2A receptor is involved in the regulation of BDNF in the
HPC (Vaidya et al., 1997).

Specifically DOI, a 5-HT2A/C receptor agonist

decreased BDNF mRNA expression in the granule cell layer of the DG but not in
the CA subfields of the HPC.

Interestingly, the decrease in BDNF mRNA

expression was blocked by the 5-HT2A receptor antagonist but not the 5-HT2C
receptor antagonist, implicating the 5-HT2A receptor in the regulation of BDNF
expression (Vaidya et al., 1997).
PSOP and 251-NBMeO exert their effects through binding to 5-HT
receptors. PSOP binds to the 5-HT2A receptor (Ki = 6 nM) with high affinity and
to a much lesser extent to the 5-HT1A receptor subtype (Ki = 190 nM) (McKenna
et al., 1990).

The synthetic phenethylamine 251-NBMeO binds to 5-HT2A

receptors (Ki = 0.044 nM) with an extremely high affinity (Braden et al., 2006).
5-HT2A receptors are highly expressed throughout the HPC in the DG,
hilus, CA1, and CA3 and are colocalized on GABAergic neurons, pyramidal and
granular cells (Cornea-Hebert et al., 1999; Morilak et al., 1993; Pompeiano et al.,
1994; Shen & Andrade, 1998; Luttgen et al., 2004; Morilak et al., 1994). 5-HT2A
receptor

agonists

stimulate

arachidonic
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acid

and

consequently,

the

phosphoinositide (PI) pathway resulting in the activation of protein kinase C
(PKC) (Kurrasch-Orbaugh et al., 2003; Ananth et al., 1987). Electrophysiological
evidence suggests that 5-HT2A receptors stimulate GABAergic interneurons in
the HPC (Shen & Andrade, 1998) and GABAergic interneurons in the hilus form
connections with progenitor cells in the SGZ (Wang et al., 2005).

When

progenitor cells are less than 2 weeks old the GABAergic input exerts an
excitatory influence on the progenitor cells and as the cells establish
glutamatergic synapses the GABAergic interneurons become inhibitory (Wang et
al., 2005; Zhao et al., 2006; Aimone et al., 2006). Given that 5-HT2A receptor
agonists administered chronically downregulates receptor expression, and
evidence suggests that the 5-HT2A receptor excites the GABAergic interneurons
which stimulate progenitor cells in the SGZ, one might anticipate a reduction in
neurogenesis after chronic PSOP. On the contrary, the present study reports
high doses of PSOP upregulates neurogenesis.

Based on this finding it is

plausible to suggest the increase in neurogenesis observed may be attributed to
the administration paradigm in which PSOP was given 4 times over the course of
one month so that injections were given once a week. In this administration
paradigm alterations in receptor levels may not have occurred to the extent that
occurs with daily exposure and give this highly plastic microniche time to adapt
between drug exposures.
The results shown provide evidence that the 5-HT2A receptor is involved in
the regulation of hippocampal neurogenesis.
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The data suggest that acute

administration of 5-HT2A receptor agonists and an antagonist downregulated
neurogenesis in the DG. Whereas, chronic administration of high doses of 5HT2A receptor agonists enhance hippocampal neurogenesis in the DG. Future
studies should investigate the effects of chronic administration of PSOP and
ketanserin on 5-HT2A receptor levels and neuroplasticity in the HPC.
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Chapter Three
The Effects of Psilocybin on Trace Fear Conditioning
Abstract
Aberrations in brain serotonin (5-HT) neurotransmission have been
implicated in psychiatric disorders including anxiety, depression and deficits in
learning and memory. Many of these disorders are treated with drugs which
promote the availability of 5-HT in the synapse. However, it is not clear which of
the 5-HT receptors are involved in behavioral improvements. The current study
aimed to investigate the effects of psilocybin, a 5HT2A receptor agonist on
hippocampal-dependent learning. Mice received a single injection of psilocybin
(0.1, 0.5, 1.0 or 1.5 mg/kg), ketanserin (a 5HT2A/C antagonist) or saline 24 hours
before habituation to the environment and subsequent training and testing on the
fear conditioning task. Trace fear conditioning is a hippocampal-dependent task
in which the presentation of the conditioned stimulus (CS, tone) is separated in
time by a trace interval to the unconditioned stimulus (US, shock).

All mice

developed contextual and cued fear conditioning; however, mice treated with
psilocybin extinguished the cued fear conditioning more rapidly than saline
treated mice.

Interestingly, mice given the 5HT2A/C receptor antagonist

ketanserin showed less of cued fear response than saline and psilocybin treated
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mice. Future studies should examine the temporal effects of acute and chronic
psilocybin administration on hippocampal-dependent learning tasks.
Introduction
The hippocampus (HPC) plays a critical role in learning tasks that involve
temporal encoding of stimuli (Squire et al., 1992; Squire, 1992).

The trace

classical conditioning paradigm requires temporal processing because the
conditioned stimulus (CS) and the unconditioned stimulus (US) are separated in
time by a trace interval.

Lesions to the HPC prevent trace conditioning,

indicating that it is a hippocampal-dependent task (McEchron et al., 1998; Weiss
et al., 1999).
The serotonergic system has been implicated in hippocampal-dependent
learning. Administration of selective serotonin (5-HT) uptake inhibitors (SSRIs)
produce alterations in performance on learning tasks that require the HPC (Flood
& Cherkin, 1987; Huang et al., 2004). In a knockout (KO) mouse model, central
5-HT deficient mice developed heightened contextual fear conditioning which
was reversed by intracerebroventricular microinjection of 5-HT (Dai et al., 2008).
An impairment in learning on the morris water maze was observed in 5-HT1A KO
mice along with functional abnormalities in the HPC (Sarnyai et al., 2000).
Activation of 5-HT1A receptors in the medial septum alters encoding and
consolidation in a hippocampal-dependent memory task (Koenig et al., 2008). In
addition, Lysergic acid diethylamide (LSD), a 5-HT2A receptor agonist facilitated
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learning of a brightness discrimination reversal problem (King et al., 1972; King
et al., 1974).
Evidence suggests that performance on hippocampal-dependent learning
tasks is influenced by neurogenesis in the dentate gyrus (DG) of the HPC (Van et
al., 2002; Nilsson et al., 1999; Shors et al., 2001; Shors et al., 2002; Gould et al.,
1999a; Gould et al., 1999c). This was elegantly demonstrated by Shors and
colleagues by treating animals with methylazoxymethanol acetate (MAM), an
anti-mitotic agent which eradicates the progenitor cell population in the DG
before testing mice on hippocampal-dependent and hippocampal-independent
learning tasks (Shors et al., 2001; Shors et al., 2002). MAM treated animals had
significantly fewer BrdU+ cells in the subgranular zone (SGZ) of the DG but
showed no impairment in the spatial navigation task (HPC-dependent) or delay
eyeblink

conditioning

task

(HPC-independent)

demonstrating

that

the

hippocampal progenitor cell population is not essential for these particular tasks
(Shors et al., 2002; Shors et al., 2001). In contrast, MAM severely impaired
performance on trace fear conditioning and trace eyeblink conditioning, providing
evidence for the involvement of progenitor cells in the DG in trace classical
conditioning (Shors et al., 2002; Shors et al., 2001). In addition, hippocampal
neurogenesis is influenced by serotonergic agonists.

Specifically, SSRIs

enhance the production of new born neurons in the DG of the HPC (Malberg et
al., 2000; Santarelli et al., 2003).
Psilocybin (PSOP), a tryptamine alkaloid, exerts psychoactive effects by
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altering serotonergic neurotransmission (Passie et al., 2002). PSOP binds to the
5-HT2A receptor (Ki = 6 nM) with high affinity and to a much lesser extent to the
5-HT1A receptor subtype (Ki = 190 nM) (McKenna et al., 1990). 5-HT2A receptors
are highly expressed throughout the HPC in the DG, hilus, CA1, and CA3
(Cornea-Hebert et al., 1999; Morilak et al., 1993; Pompeiano et al., 1994; Shen &
Andrade, 1998; Luttgen et al., 2004; Morilak et al., 1994).

5-HT2A receptor

agonists, including PSOP, stimulate arachidonic acid (AA) and consequently, the
phosphoinositide (PI) pathway resulting in the activation of protein kinase C
(PKC) (Kurrasch-Orbaugh et al., 2003; Ananth et al., 1987). Electrophysiological
evidence suggests that 5-HT2A receptors stimulate GABAergic interneurons in
the HPC (Shen & Andrade, 1998) and GABAergic interneurons in the hilus form
connections with progenitor cells in the SGZ (Wang et al., 2005).
The present study aimed to investigate the effects of the 5HT2A receptor
agonist PSOP on hippocampal-dependent learning.

Mice received a single

injection of psilocybin (0.1, 0.5, 1.0 or 1.5 mg/kg), 1.0 mg/kg ketanserin (a
5HT2A/C antagonist) or saline 24 hours before habituation to the environment and
subsequent training and testing on the trace fear conditioning task.
Materials and Methods
Subjects.

C57BL/6J male mice (30-40g) were housed in standard

laboratory cages and left undisturbed for 1 week after arrival at the animal facility.
All mice had unlimited access to water and laboratory chow and were maintained
in a temperature and humidity controlled room on a 12:12 light/dark cycle with
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light onset at 7:00

AM.

All National Institutes for Health (NIH) guidelines for the

Care and Use of Laboratory Animals were followed (National Institutes of Health,
2002).
General Procedure. Mice (n=9-10/condition) received an intraperitoneal
(i.p.) injection of PSOP (0.1 mg/kg, 0.5 mg/kg, 1.0 mg/kg, 1.5 mg/kg), ketanserin
(1.0 mg/kg) or 0.9% saline and 24 h later were habituated to the testing chamber
for 30 min. The fear conditioning environment consisted of two chambers each
placed inside a larger soundproof chamber. The 35.6 (W) x 38.1 (D) x 31.8 (H)
cm freeze monitor box (San Diego Instruments, San Diego, CA) is a clear
Plexiglas chamber with a removable lid which contains a metal grid floor (0.3 cm
grids spaced 0.8 cm apart) through which a foot shock can be delivered. Photobeam activity within the chamber recorded the vertical and horizontal movements
of mice. Two minutes into the habituation period a baseline (BL) measure of
movement was recorded for 3 minutes and served as the habituation BL
measure. Freeze monitor boxes were cleaned with quatricide between each
mouse to prevent olfactory cues. Mice were returned to their home cage after
habituation.
The next day mice were returned to the same freeze monitor chamber and
underwent training to form CS – US associations. After a 2 minute acclimation
period, mice were exposed to 10 trials of trace fear conditioning which is
illustrated in Figure 3.1.

Each trial consisted of the CS (tone, 82 dB, 15 s)

followed by a trace interval (30 s) and ended with the presentation of the US
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(shock, 0.5 s, 1 mA) delivered through the grid flooring. After each trial ended
there was a 210 s intertrial interval (ITI). Freeze monitor boxes were cleaned
with quatricide between each mouse to prevent olfactory cues and mice were
returned to their home cage after training.

Figure 3.1. Schematic representation of the Trace Fear Conditioning Paradigm.
Trace fear conditioning is a hippocampal-dependent task in which the
presentation of the conditioned stimulus (CS, tone) is separated in time by a
trace interval to the unconditioned stimulus (US, shock)

On day 3 of the task, testing of the fear conditioning response was
assessed in 2 phases. First, mice were placed in the freeze monitor box for 5
minutes and movement was recorded for the last 3 minutes and used to assess
the measure of fear associated to the training context. Mice were then returned
to the home cage for 1 hour. Second, the context was altered by replacing the
grid floors with black Plexiglas flooring and adding a cotton ball with 1ml vanilla
essence inside the sound attenuated chamber. Mice were placed inside the
novel chamber and after 2 minutes, movements were recorded for the next 3
minutes. Next 10 trials with the presentation of the CS only were delivered with
an ITI of 240 s. Cue fear conditioning was measure by the percent freezing
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during the CS (tone; 15s), during the trace interval (30s) and after the trace when
the US would have occurred. Conditioned fear was defined as an increase in
percent immobility during the cue test. Percent immobility was calculated by
dividing time spent immobile during stimuli (CS, trace or after trace) by the length
of time the stimuli lasted multiplied by 100.
Design and analyses. Separate two-way repeated measure analyses of
variance (ANOVA) were used to evaluate the effect of Dose and Trial on each
dependent variable in the trace fear conditioning task. Dependent measures
recorded included percent freezing during CS, during trace, after trace, during
habituation BL, during the context text and in response to the novel environment.
When appropriate, post hoc analyses such as Bonforreoni were used to isolate
effects. All statistical analyses will be determined significant at the 0.05 alpha
level.
Results
Acquisition.

The acquisition of the freezing response is displayed in

Figure 3.2 showing both the response to the CS (Figure 3.2A) and during the
trace (Figure 3.2B). Using percent immobility in response to the CS for the first 3
trials of training, ANOVA showed that regardless of drug treatment there was a
significant improvement across trial [F(2, 108) = 40.0, p<0.0001]. Specifically,
immobility in response to the CS increased from trial 1 to trial 3 indicating the
learned association between the stimuli during training (p<0.05). Additionally,
ANOVA of the percent immobility during the trace interval revealed a significant
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effect of trial [F(2, 108) = 20.0, p<0.0001]. There was a striking increase in the
amount of time spent immobile during the trace period from trial 1 to trial 3
demonstrating that the association between the CS and US promoted immobility
in anticipation of the shock.
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Figure 3.2. Effects of Psilocybin on the Acquisition of Trace Fear Conditioning.
Mice underwent training to form CS – US associations by exposure to 10 trials of
trace fear conditioning. Each trial consisted of the presentation of the CS (tone,
15-s) followed by a trace interval (30-s) and ended with the US (shock, 0.5-s). A)
Percent immobility during presentation of the 15-s CS during the first three trials
of CS – US pairing. B) Percent immobility during the 30-s trace interval during
the first three trials of CS – US pairing.

Contextual Fear Conditioning. Contextual fear conditioning was assessed
by comparing percent immobility in the freeze monitor box on habituation day to
percent immobility during the context test. There was no interaction between
Dose and Trial [F(5,90) = 0.95, p=0.45] and no effect of Dose during the
habituation BL or context test [F(5,90) = 1.15, p=0.34]. However, there was a
significant effect of Trial [F(1,90) = 105.85, p<0.0001] indicating that mice spent
significantly more time freezing after the CS – US pairings during the context test
compared to habituation BL.

Figure 3.3 illustrates percent immobility during

exposure to the freeze monitor box during the habituation test (A) and during the
contextual fear conditioning test (B).
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Figure 3.3. Contextual Fear Conditioning. Percent immobility expressed during

65

exposure to the freeze monitor box during habituation (A) and during contextual
fear conditioning (B).

All mice expressed contextual fear conditioning as

indicated by a significant increase in percent immobility during the context test
(p<0.05).

Cue Fear Conditioning. Freezing responses (% immobility) during the CS
only (tone) test are illustrated in Figure 3.4. There was a significant effect of Trial
[F(2,102) = 7.83, p<0.0007] with trials 2 and 3 eliciting significantly more freezing
in response to the CS compared to trial 1 (Figure 3.4A). There was also a
significant effect of Dose [F(5,51) = 4.96, p<0.0009] revealing that control mice
showed a greater fear response to the cue compared to 0.1 mg/kg PSOP, 1.0
mg/kg PSOP, 1.5 mg/kg PSOP and 1.0 mg/kg ketanserin. ANOVA revealed a
significant effect of Dose during the trace interval [F(5,51) = 2.41, p<0.05]. The
fear associated with the trace interval during the first three trials on test day was
reduced in mice treated with 1.0 mg/kg PSOP compared to saline and 1.5 mg/kg
PSOP (Figure 3.4B). Figure 3.4C illustrates the fear response after the trace
interval which coincides with the timing the US (shock) was delivered during the
acquisition of the CS - US pairing phase. A two-way repeated measures ANOVA
revealed a significant interaction between Dose and Trial [F(10,100) = 3.53,
p<0.0005]. Interestingly, mice administered low doses of PSOP (0.1 and 0.5
mg/kg) froze more on trial 1 compared to trial 2 and 3 suggesting they are more
apt to adapt to the absence of the US so that the fear response is diminished as
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the US is extinguished.

This pattern was reversed in mice treated with

ketanserin who increased fear responses from trials 1 to 3, indicating the robust
memory for the US even in its absence. Taken together, these data suggest
differential effects of PSOP on trace fear conditioning.
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Figure 3.4.

Effect of Acute PSOP on Cue Fear Conditioning.

Cue fear

conditioning was examined 24 hours after the training period in which mice were
exposed to 10 trials of CS – US pairings.

A)

Percent immobility during

presentation of the 15-s CS during the first three CS-only trials. B) Percent
immobility during the 30-s trace interval during the first three trials. C) Percent
immobility after the trace interval which coincides with the timing the US (shock)
was delivered during the acquisition of the CS - US pairing phase.

Discussion
The present investigation illustrates the involvement of the 5-HT2A receptor
in trace fear conditioning, a hippocampal-dependent learning task. During the
acquisition of the freezing response there was a striking increase in the amount
of time spent freezing during the presentation of the CS and during the trace
period from trial 1 to trial 3 (see Figure 3.2). These data demonstrate that the
association between the CS and US promoted freezing in anticipation of the
shock, however, the acquisition of learning was not altered by acute
administration of PSOP or ketanserin.
All conditions displayed similar locomotor activity levels in the freeze
monitor box during the habituation baseline exposure and during re-exposure to
the same environment during the contextual fear conditioning test. As expected
mice froze substantially more during re-exposure to the same context after CS –
US associations were formed compared to the habituation baseline, indicating
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that all groups formed contextual fear conditioning (Figure 3.3). It is well known
that contextual fear conditioning is a hippocampal-dependent learning task (Kim
& Fanselow, 1992; McNish et al., 1997; Hirsh, 1974; Esclassan et al., 2008;
Frohardt et al., 1999).

The serotonergic system has been implicated in

performance on the contextual fear conditioning task (Dai et al., 2008). The
present investigation found that the 5-HT2A receptor does not alter contextual
fear conditioning since no differences were observed between controls and mice
treated with PSOP or ketanserin.
The current study reports alterations in cue associated fear conditioning
mediated by the 5-HT2A receptor. Independent of drug administered all mice
developed cue-induced freezing during the presentation of the tone on the CSonly trial (see Figure 3.4). At the time coinciding with the expected US (shock)
presentation low doses of PSOP (0.1 and 0.5 mg/kg) elicited a heightened
freezing response on trial 1 compared to other trials suggesting they are more
apt to adapt to the absence of the US so that the fear response is diminished as
the US is extinguished.

This pattern was reversed in mice treated with

ketanserin who increased fear responses from trials 1 to 3, indicating the robust
memory for the US even in its absence.
Synaptic plasticity in the HPC is critical for the acquisition of learning and
memory.

Brain derived neurotropic factor (BDNF) has been implicated in

synaptic plasticity and memory processing (Kang et al., 1997; Pang et al., 2004;
Tyler et al., 2002) through the modulation of synapse formation and dendritic
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spine growth in the HPC (Bamji et al., 2006; Tyler & Pozzo-Miller, 2001; Tyler &
Pozzo-Miller, 2003). Chronic administration of 5-HT agonists (including SSRIs)
upregulate BDNF mRNA expression in the HPC (Nibuya et al., 1995; Nibuya et
al., 1996).
Evidence suggests that the 5-HT2A receptor is involved in the regulation of
BDNF in the HPC (Vaidya et al., 1997). Specifically DOI, a 5-HT2A/C receptor
agonist decreased BDNF mRNA expression in the granule cell layer of the DG
but not in the CA subfields of the HPC. Interestingly, the decrease in BDNF
mRNA expression was blocked by the 5-HT2A receptor antagonist but not the 5HT2C receptor antagonist, implicating the 5-HT2A receptor in the regulation of
BDNF expression (Vaidya et al., 1997).
5-HT2A receptors are highly expressed throughout the HPC in the DG,
hilus, CA1, and CA3 and are colocalized on GABAergic neurons, pyramidal and
granular cells (Cornea-Hebert et al., 1999; Morilak et al., 1993; Pompeiano et al.,
1994; Shen & Andrade, 1998; Luttgen et al., 2004; Morilak et al., 1994).
Agonists to the 5-HT2A receptor stimulate AA and consequently, the PI pathway
resulting in the activation of PKC (Kurrasch-Orbaugh et al., 2003; Ananth et al.,
1987). Electrophysiological evidence suggests that 5-HT2A receptors stimulate
GABAergic interneurons in the HPC (Shen & Andrade, 1998). Aberrations in
GABAergic function in the HPC has been implicated in learning and memory due
to the role of hippocampal GABA in temporospatial integration (Wallenstein et al.,
1998)
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Taken together, the data reported in the present investigation implicate the
5-HT2A receptor in hippocampal-dependent learning. The present study reports
that prior exposure to PSOP altered responsivity in a novel environment
indicating an absence of a fear response, an effect not elicited by control mice.
Furthermore, low doses of PSOP heightened cue elicited fear conditioning and
antagonists to the 5-HT2A/C receptor diminished fear conditioning to the cue.
Results of this study raise the possibility that 5-HT2A receptor activity could lead
alterations hippocampal-dependent learning and memory.
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